Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Bravi

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Pharmacogenetics|April 26, 2000
Three and four dimensional-quantitative structure activity relationship (3D/4D-QSAR) analyses of CYP2D6 inhibitorsS Ekins, G Bravi, S Binkley, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 20, 2000
Three- and four-dimensional-quantitative structure activity relationship (3D/4D-QSAR) analyses of CYP2C9 inhibitorsS Ekins, G Bravi, S Binkley, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 25, 1999
Three- and four-dimensional quantitative structure activity relationship analyses of cytochrome P-450 3A4 inhibitorsS Ekins, G Bravi, S Binkley, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 23, 1998
Three-dimensional quantitative structure activity relationship analyses of substrates for CYP2B6S Ekins, G Bravi, B J Ring, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Pharmacogenetics|April 26, 2000
Three and four dimensional-quantitative structure activity relationship (3D/4D-QSAR) analyses of CYP2D6 inhibitorsS Ekins, G Bravi, S Binkley, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 20, 2000
Three- and four-dimensional-quantitative structure activity relationship (3D/4D-QSAR) analyses of CYP2C9 inhibitorsS Ekins, G Bravi, S Binkley, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 25, 1999
Three- and four-dimensional quantitative structure activity relationship analyses of cytochrome P-450 3A4 inhibitorsS Ekins, G Bravi, S Binkley, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 23, 1998
Three-dimensional quantitative structure activity relationship analyses of substrates for CYP2B6S Ekins, G Bravi, B J Ring, et al.
Pageof 2